Pharmaniaga Bhd
KLSE:PHARMA
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| MY |
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
1.9B MYR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
118.6B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.9B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.8B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.3B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
36.5B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
68.2B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -634.5% |
| 30th Percentile | 14.4% |
| Median | 23.9% |
| 70th Percentile | 35.3% |
| Max | 247.9% |
Other Profitability Ratios
Pharmaniaga Bhd
Glance View
Pharmaniaga Bhd.operates as an investment holding company. The company is headquartered in Shah Alam, Selangor. The firm is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company’s segment includes Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution segment is engaged in the distribution, trading, and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is involved in manufacturing of pharmaceutical products in Malaysia. The Indonesia segment is engaged manufacturing and distribution of pharmaceutical and medical products in Indonesia. Its subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Pharmaniaga Bhd is 10.7%, which is below its 3-year median of 11.3%.
Over the last 3 years, Pharmaniaga Bhd’s Gross Margin has decreased from 13.6% to 10.7%. During this period, it reached a low of -6% on Dec 31, 2022 and a high of 14.4% on Dec 31, 2024.
